Drug Shortage Report for HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION

Last updated on 2023-09-07 History
Report ID 172620
Drug Identification Number 01990748
Brand name HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
Common or Proper name HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 2UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 12 x 1L bag
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-26
Estimated end date
Actual end date 2023-09-06
Shortage status Resolved
Updated date 2023-09-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-09-07 English Compare
v9 2023-09-06 French Compare
v8 2023-09-06 English Compare
v7 2023-08-31 French Compare
v6 2023-08-31 English Compare
v5 2023-08-17 French Compare
v4 2023-08-17 English Compare
v3 2022-10-27 English Compare
v2 2022-10-26 French Compare
v1 2022-10-26 English Compare

Showing 1 to 10 of 10